Medtronic plc
MDTHealthcareNASDAQMedical Devices · Last scanned Jun 3, 2026
Scan Results
Daily timeframePart of the healthcare sector, Medtronic plc (MDT) is listed under Medical Devices. The company carries a $94.69B market cap, placing it firmly in the large-cap category. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Market Cap
$94.69B
Beta
0.63
P/E (TTM)
20.60
P/E (Fwd)
12.17
EPS (TTM)
$3.58
EPS (Fwd)
$6.06
ROE
9.4%
ROA
4.6%
Cash
$8.38B
Total Debt
$28.07B
Free CF
$4.07B
52W Change
-13.8%
Annual Financials
Cash vs Debt
The company holds $8.38B in cash, though total debt stands at $28.07B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $4.07B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 9.4% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.6% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $31.69B (2022) to $33.54B (2025).
With a beta below 0.7, Medtronic plc typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Medtronic plc and its sector.